# Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

> **NCT04789044** · PHASE2 · RECRUITING · sponsor: **Major Extremity Trauma Research Consortium** · enrollment: 40 (estimated)

## Conditions studied

- Peripheral Nerve Injuries

## Interventions

- **DRUG:** NTX-001

## Key facts

- **NCT ID:** NCT04789044
- **Lead sponsor:** Major Extremity Trauma Research Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04789044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04789044, "Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04789044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*